RT Book, Section A1 Ellison, E. Christopher A1 Zollinger, Jr., Robert M. A1 Pawlik, Timothy M. A1 Vaccaro, Patrick S. A1 Bitans, Marita A1 Baker, Anthony S. SR Print(0) ID 1187824718 T1 Iliac Artery Occlusive Disease, Endovascular Stenting T2 Zollinger’s Atlas of Surgical Operations, 11e YR 2022 FD 2022 PB McGraw-Hill Education PP New York, NY SN 9781260440850 LK accesssurgery.mhmedical.com/content.aspx?aid=1187824718 RD 2024/03/28 AB Patients with iliac artery stenosis often will have concomitant lower extremity or aortic peripheral arterial disease. Isolated iliac occlusive disease typically produces ipsilateral hip, thigh, or buttock claudication, whereas when found concomitantly with superficial femoral or tibial occlusive disease, it can manifest as limb-threatening ischemia (rest pain, nonhealing wounds, or gangrene). When to intervene on an isolated iliac artery stenosis depends on the degree of patient symptoms and patient risk factors, which may increase the risk of an intervention. A trial of cilastazol can be instituted first but typically is not as successful in the face of isolated iliac artery occlusive disease. Modification of atherosclerotic risk factors should be undertaken as soon as recognized in order to improve long-term patient outcomes. This may include smoking cessation, hypertension control, lipid profile improvement, and diabetes management.